Back to today’s briefing

Story perspectives

Breakthrough in CAR-T Therapy Boosts Cancer Treatment Efficacy

2/10/2025

37 5

Summary

Story summary

Researchers are revolutionizing CAR-T cell therapy for blood cancers, such as leukemia and lymphoma, by enhancing the CUL5 gene. This breakthrough boosts the effectiveness and lifespan of immune cells, potentially lowering cancer recurrence. Meanwhile, CTMC is fast-tracking cell therapy advancements by merging manufacturing with clinical processes, striving to improve treatments for solid tumors and elevate patient care.

1 of 1

Story summary

Researchers are revolutionizing CAR-T cell therapy for blood cancers, such as leukemia and lymphoma, by enhancing the CUL5 gene. This breakthrough boosts the effectiveness and lifespan of immune cells, potentially lowering cancer recurrence. Meanwhile, CTMC is fast-tracking cell therapy advancements by merging manufacturing with clinical processes, striving to improve treatments for solid tumors and elevate patient care.